Vanguard Group
SCPH icon

Vanguard Group’s scPharmaceuticals SCPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.99M Sell
1,835,649
-157,111
-8% -$599K ﹤0.01% 3087
2025
Q1
$5.24M Sell
1,992,760
-115,697
-5% -$304K ﹤0.01% 3152
2024
Q4
$7.46M Buy
2,108,457
+399,511
+23% +$1.41M ﹤0.01% 3100
2024
Q3
$7.79M Buy
1,708,946
+322,750
+23% +$1.47M ﹤0.01% 3079
2024
Q2
$6.03M Buy
1,386,196
+16,360
+1% +$71.2K ﹤0.01% 3176
2024
Q1
$6.88M Sell
1,369,836
-52
-0% -$261 ﹤0.01% 3152
2023
Q4
$8.59M Buy
1,369,888
+150,871
+12% +$946K ﹤0.01% 3033
2023
Q3
$8.68M Buy
1,219,017
+26,011
+2% +$185K ﹤0.01% 2959
2023
Q2
$12.2M Buy
1,193,006
+193,039
+19% +$1.97M ﹤0.01% 2830
2023
Q1
$9.07M Buy
999,967
+122,959
+14% +$1.12M ﹤0.01% 2987
2022
Q4
$6.29M Buy
877,008
+260,450
+42% +$1.87M ﹤0.01% 3192
2022
Q3
$4.02M Hold
616,558
﹤0.01% 3429
2022
Q2
$2.97M Hold
616,558
﹤0.01% 3632
2022
Q1
$3.5M Hold
616,558
﹤0.01% 3702
2021
Q4
$3.1M Sell
616,558
-490
-0.1% -$2.46K ﹤0.01% 3864
2021
Q3
$4.1M Buy
617,048
+8,100
+1% +$53.9K ﹤0.01% 3780
2021
Q2
$3.72M Sell
608,948
-34,507
-5% -$211K ﹤0.01% 3745
2021
Q1
$4.28M Buy
643,455
+8,491
+1% +$56.5K ﹤0.01% 3608
2020
Q4
$3.36M Buy
634,964
+45,288
+8% +$240K ﹤0.01% 3510
2020
Q3
$4.39M Buy
589,676
+2,077
+0.4% +$15.5K ﹤0.01% 3212
2020
Q2
$4.33M Buy
587,599
+343,634
+141% +$2.53M ﹤0.01% 3163
2020
Q1
$1.81M Sell
243,965
-12,168
-5% -$90K ﹤0.01% 3337
2019
Q4
$1.45M Hold
256,133
﹤0.01% 3537
2019
Q3
$1.52M Buy
256,133
+167,172
+188% +$989K ﹤0.01% 3534
2019
Q2
$284K Sell
88,961
-71,735
-45% -$229K ﹤0.01% 3915
2019
Q1
$482K Sell
160,696
-86
-0.1% -$258 ﹤0.01% 3779
2018
Q4
$604K Sell
160,782
-45,137
-22% -$170K ﹤0.01% 3689
2018
Q3
$1.21M Sell
205,919
-3,339
-2% -$19.6K ﹤0.01% 3676
2018
Q2
$1.18M Buy
209,258
+6,314
+3% +$35.7K ﹤0.01% 3644
2018
Q1
$2.52M Buy
202,944
+22,944
+13% +$284K ﹤0.01% 3379
2017
Q4
$2.18M Buy
+180,000
New +$2.18M ﹤0.01% 3396